Diabetes, Vol 31, Issue 2 185-188, Copyright © 1982 by American Diabetes Association

ARTICLES

Alterations in the basement membrane (heparan sulfate) proteoglycan in diabetic mice

DH Rohrbach, JR Hassell, HK Kleinman and GR Martin

We have grown the EHS (Engelbreth-Holm, Swarm) tumor in normal and genetically diabetic mice (db/db) and measured some components of basement membrane produced in the tumor. These studies showed similar amounts of total protein in control and diabetic tissue and similar patterns of proteins on SDS gel electrophoresis of extracts of the tissue. Laminin, a basement membrane specific glycoprotein utilized as an attachment factor by epithelial cells, was present in increased amounts in diabetic tissue. In contrast, the amount of BM-1 (heparan sulfate) proteoglycan was reduced. Less 35S-sulfate was incorporated into this proteoglycan, and the proteoglycan, but not its component glycosaminoglycans, was heterogeneous in size. The data indicate that either the synthesis of proteoglycan was decreased or its degradation was increased in diabetic tissue. Since the heparan sulfate proteoglycan serves to block the passage of anionic macromolecules through the basement membrane, decreased levels could account for the increased porosity of diabetic basement membrane. Compensatory synthesis of the basement membrane components to restore normal permeability could account for the thickened basement membranes observed in diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. B. Maxhimer, M. Somenek, G. Rao, C. E. Pesce, D. Baldwin Jr., P. Gattuso, M. M. Schwartz, E. J. Lewis, R. A. Prinz, and X. Xu Heparanase-1 Gene Expression and Regulation by High Glucose in Renal Epithelial Cells: A Potential Role in the Pathogenesis of Proteinuria in Diabetic Patients Diabetes, July 1, 2005; 54(7): 2172 - 2178. [Abstract] [Full Text] [PDF]

				I. Coronado-Pons, A. Novials, S. Casas, A. Clark, and R. Gomis Identification of iduronate-2-sulfatase in mouse pancreatic islets Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E983 - E990. [Abstract] [Full Text] [PDF]

				G. GAMBARO and F. J. VAN DER WOUDE Glycosaminoglycans: Use in Treatment of DiabeticNephropathy J. Am. Soc. Nephrol., February 1, 2000; 11(2): 359 - 368. [Full Text] [PDF]

				G. N. Jyothirmayi, I. Alluru, and A. S. Reddi Doxazosin Prevents Proteinuria and Glomerular Loss of Heparan Sulfate in Diabetic Rats Hypertension, May 1, 1996; 27(5): 1108 - 1114. [Abstract] [Full Text]

				S. Joseph, M. Ford, C Barth, S Portbury, P. Bartlett, V Nurcombe, and U Greferath A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant Development, January 11, 1996; 122(11): 3443 - 3452. [Abstract] [PDF]

				M. D Flynn and J. E Tooke Microcirculation and the diabetic foot Vascular Medicine, September 1, 1990; 1(2): 121 - 138. [PDF]